Imagen de Portada

Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Anna L. Parks, Ayush Thacker, Daniel Dohan, Liliana A. Ramirez Gomez, Seth A. Gale, Kim G. Johnson, Christine S. Ritchie, Sachin J. Shah, Joanna Paladino
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

“I’m worth saving”‐ a qualitative study of people with dementia considering treatment with lecanemab
por: Ayush Thacker, et al.
Publicado: (2024)

Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
por: Pratik Bhagunde, et al.
Publicado: (2026)

Bayesian meta‐analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high‐dose gantenerumab in prodromal and mild Alzheimer's disease
por: Stefan J. Teipel, et al.
Publicado: (2024)

Clinical efficacy of anti‐amyloid antibodies in apolipoprotein E ε4 homozygotes: A Bayesian reanalysis of lecanemab and donanemab phase 3 results
por: Stefan Teipel, et al.
Publicado: (2025)

Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual‐level data from the A4 study of solanezumab
por: Sarah F. Ackley, et al.
Publicado: (2026)

Comprehensive intervention combining group and personalized language therapy in primary progressive aphasia: Quantitative and qualitative findings
por: Tijana Simic, et al.
Publicado: (2025)

Sex differences in blood pressure hemodynamics and white matter hyperintensity volume across racial ethnic groups—HABS‐HD
por: Cellas A. Hayes, et al.
Publicado: (2026)

Person‐centered care at population scale: The Swedish registry for behavioral and psychological symptoms of dementia
por: Linus Jönsson, et al.
Publicado: (2025)

Differential relationships between cardiorespiratory fitness and cortical thickness across the adult lifespan: A generalized additive model approach
por: Jillian H. Graham, et al.
Publicado: (2026)

Participant completion of longitudinal assessments in an online cognitive aging registry: The role of medical conditions
por: Miriam T. Ashford, et al.
Publicado: (2024)

Modeling amyloid plaque turnover dynamics improves characterization of drug effects
por: Eline van Maanen, et al.
Publicado: (2025)

Neurovascular de‐coupling underlies dual‐task cost across cognitive abilities
por: Laura K. Fitzgibbon‐Collins, et al.
Publicado: (2025)

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach
por: Jamie C. Fong, et al.
Publicado: (2026)

Implementing Anti‐Amyloid Therapies in Memory Clinics: A Qualitative Study of Clinician Experiences and Practice Changes
por: Ayush Thacker, et al.
Publicado: (2025)

Adaptive measurement of cognitive function based on multidimensional item response theory
por: Robert D. Gibbons, et al.
Publicado: (2024)

Directionality between cognitive function and daily physical activity patterns
por: Francesca R. Marino, et al.
Publicado: (2025)

How generative AI reconfigure clinician–AI and clinician–patient relationships
por: Tianyi Shen, et al.
Publicado: (2026)

Predicting regional tau accumulation with machine learning‐based tau‐PET and advanced radiomics
por: Saima Rathore, et al.
Publicado: (2024)

Characterizing Clinician Communication with Patients about Lecanemab: A Qualitative Study of Clinicians across Seven Academic Medical Centers
por: Ayush Thacker, et al.
Publicado: (2025)

Activity variability: A novel physical activity metric and its association with cognitive impairment
por: Patrick T. Donahue, et al.
Publicado: (2025)

Response to: Refining the clinical interpretation of activity variability in cognitive impairment: The need for phenotypic specificity
por: Patrick T. Donahue, et al.
Publicado: (2025)

Anticholinergic drugs and dementia risk: Using stem cell–based studies to complement pharmacoepidemiology
por: Tiara A. Schwarze‐Taufiq, et al.
Publicado: (2025)

Low intrinsic capacity is associated with a blunted exercise‐induced cognitive enhancement in physically active middle‐aged and older adults
por: Brandon A. Yates, et al.
Publicado: (2025)

Impact of study partner replacement in a mild cognitive impairment clinical trial
por: Lucy A. Dolmadjian, et al.
Publicado: (2025)

Single‐subject proteomic signatures in Alzheimer's disease reflect clinical phenotypes and distinguish asymptomatic from symptomatic cases
por: Avijit Podder, et al.
Publicado: (2026)

Exercise intensity matters: A review on evaluating the effects of aerobic exercise intensity on muscle‐derived neuroprotective myokines
por: Navabeh Zare, et al.
Publicado: (2025)

The interaction effect of physical activity and sleep on cognitive function in stroke
por: Ryan G. Stein, et al.
Publicado: (2025)

Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action
por: Mark A. Dubbelman, et al.
Publicado: (2024)

Distribution of insulin in primate brain following nose‐to‐brain transport
por: Kylie Smith, et al.
Publicado: (2024)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
por: Chao‐Yi Wu, et al.
Publicado: (2025)

Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease
por: Garrett R. Mullins, et al.
Publicado: (2025)

Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research
por: Zvinka Z. Zlatar, et al.
Publicado: (2026)

Evaluation of racial and ethnic heterogeneity in the associations of sleep quality and sleep apnea risk with cognitive function and cognitive decline
por: Ruijia Chen, et al.
Publicado: (2024)

Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
por: Gregory A. Cary, et al.
Publicado: (2024)

Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design
por: Michael K. Leuchter, et al.
Publicado: (2025)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
por: Luke E. Stoeckel, et al.
Publicado: (2025)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease
por: Inga Margret Antonsdottir, et al.
Publicado: (2024)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
por: Bernadette A. Fausto, et al.
Publicado: (2026)

Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes
por: Claire M. Erickson, et al.
Publicado: (2024)

Implications of practice effects for the design of Alzheimer clinical trials
por: Jasmin A. Duehring, et al.
Publicado: (2025)